<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952558/" ref="ordinalpos=302&amp;ncbi_uid=5911491&amp;link_uid=PMC3952558" image-link="/pmc/articles/PMC3952558/figure/F2/" class="imagepopup">Figure 2.  From: Topographical changes in extracellular matrix: Activation of TLR4 <span class="highlight" style="background-color:">signaling</span> and solid tumor progression. </a></div><br /><div class="p4l_captionBody">TLR4 Signaling Pathway. LPS-induced activation of TLR4 is mediated by CD14. CD14 delivers LPS to TLR4/MD-2 complex and downstream signaling is divided into MyD88-dependent and independent signaling. MyD88-dependent signaling results in the rapid activation of NF-κB and the induction of pro-inflammatory cytokines, while MyD88-independent signaling results in late activation of NF-κB and induction of type I interferons.</div></div>